Cargando…
Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling
Hepatocellular carcinoma (HCC) accounts for most liver cancer cases worldwide. Contraction of the hepatitis C virus (HCV) is considered a major risk factor for liver cancer. In order to identify the risk of cancer, metabolic profiling of serum samples from patients with HCC (n=40) and HCV (n=22) was...
Autores principales: | Wei, Siwei, Suryani, Yuliana, Gowda, G. A. Nagana, Skill, Nicholas, Maluccio, Mary, Raftery, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901236/ https://www.ncbi.nlm.nih.gov/pubmed/24957758 http://dx.doi.org/10.3390/metabo2040701 |
Ejemplares similares
-
Quantitating Metabolites in Protein Precipitated Serum Using NMR Spectroscopy
por: Gowda, G. A. Nagana, et al.
Publicado: (2014) -
Expanding the Limits
of Human Blood Metabolite Quantitation
Using NMR Spectroscopy
por: Nagana Gowda, G. A., et al.
Publicado: (2014) -
Esophageal Cancer Metabolite Biomarkers Detected by LC-MS and NMR Methods
por: Zhang, Jian, et al.
Publicado: (2012) -
A new limit for blood metabolite analysis using (1)H NMR spectroscopy
por: Nagana Gowda, G.A., et al.
Publicado: (2022) -
Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls
por: Lohavanichbutr, Pawadee, et al.
Publicado: (2018)